VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
42 hedge funds and large institutions have $248M invested in Verona Pharma in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 7.71% → 7.69% (-0.01%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
97% less call options, than puts
Call options by funds: $12K | Put options by funds: $409K
Holders
42
Holding in Top 10
4
Calls
$12K
Puts
$409K
Top Buyers
| 1 | +$3.61M | |
| 2 | +$820K | |
| 3 | +$104K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$82K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
+$80K |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$1.35M | |
| 3 | -$144K | |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$102K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$73.9K |